반응식
[Br:1][C:2]1[CH:7]=[CH:6][N:5]2[C:8]([C:11](NC3C=C(C=CC=3F)C(O)=O)=[O:12])=[CH:9][N:10]=[C:4]2[CH:3]=1.[NH2:24][C:25]1[C:26]([CH3:35])=[N:27][CH:28]=[C:29]([CH:34]=1)[C:30]([O:32][CH3:33])=[O:31]>>[Br:1][C:2]1[CH:7]=[CH:6][N:5]2[C:8]([C:11]([NH:24][C:25]3[C:26]([CH3:35])=[N:27][CH:28]=[C:29]([CH:34]=3)[C:30]([O:32][CH3:33])=[O:31])=[O:12])=[CH:9][N:10]=[C:4]2[CH:3]=1참가 물질
3
실험 절차
The title compound was prepared from 7-bromoimidazo[1,2-a]pyridine-3-carboxylic acid (Intermediate 1A, step 3) and methyl 5-amino-6-methylnicotinate (step 2) analogously to Intermediate 1A;
출처 및 근거
- ORD 기록
- ord-f05258628aa2480dac88ccb4a6c0116d
- 출처 데이터셋
- uspto-grants-2014_11
- 특허 번호
- US08883819B2
연결된 노트
불러오는 중…